Back to Search
ASHISH JANI, M.D.
M.D.
Radiation Oncology Physician
NPI: 1770879223IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
284617(NY)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
OTHER
Class of 2011
Research & Publications (20)
External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity?
PMID 19464123·Int J Radiat Oncol Biol Phys·2010
8-other
PET lesion segmentation using automated iso-intensity contouring in head and neck cancer.
PMID 19645517·Technol Cancer Res Treat·2009
8-other
Performance evaluation of Calypso 4D localization and kilovoltage image guidance systems for interfraction motion management of prostate patients.
PMID 19526184·ScientificWorldJournal·2009
8-other
Case study of anti-1-amino-3-F-18 fluorocyclobutane-1-carboxylic acid (anti-[F-18] FACBC) to guide prostate cancer radiotherapy target design.
PMID 19387202·Clin Nucl Med·2009
5-case
A 220-nucleotide deletion of the intronic enhancer reveals an epigenetic hierarchy in immunoglobulin heavy chain locus activation.
PMID 19414554·J Exp Med·2009
7-preclinical
Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer.
PMID 18952307·Radiother Oncol·2009
8-other
Dose-escalated radiation therapy for intermediate-risk prostate cancer: patient selection for androgen deprivation therapy using percentage of positive cores.
PMID 19208426·Cancer·2009
8-other
Lanthanide complexes on Ag nanoparticles: designing contrast agents for magnetic resonance imaging.
PMID 19527906·J Colloid Interface Sci·2009
8-other
Molecular basis of CD4 repression by the Swi/Snf-like BAF chromatin remodeling complex.
PMID 19180471·Eur J Immunol·2009
7-preclinical
Biochemical control and toxicity after intensity-modulated radiation therapy for prostate cancer.
PMID 19445537·Technol Cancer Res Treat·2009
8-other
Pelvic shape and prostate motion: implications for target volume design and analysis of acute toxicity.
PMID 19433967·Am J Clin Oncol·2009
8-other
International collaborations in radiation oncology: a single-institution experience in academic outreach.
PMID 18755441·J Am Coll Radiol·2008
8-other
A novel genetic strategy reveals unexpected roles of the Swi-Snf-like chromatin-remodeling BAF complex in thymocyte development.
PMID 18955569·J Exp Med·2008
7-preclinical
Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease?
PMID 18234446·Int J Radiat Oncol Biol Phys·2008
8-other
Phenotyping of cytochrome P450 3A enzyme in Gujarat population.
PMID 19356063·Drug Metab Lett·2008
3-trial
Interleukin-18 binding protein transgenic mice are protected against ischemic acute kidney injury.
PMID 18753296·Am J Physiol Renal Physiol·2008
7-preclinical
Long-term renal outcomes after delayed graft function.
PMID 18565476·Adv Chronic Kidney Dis·2008
6-review
HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium.
PMID 18502984·Invest Ophthalmol Vis Sci·2008
7-preclinical
Age and grade trends in prostate cancer (1974-2003): a Surveillance, Epidemiology, and End Results Registry analysis.
PMID 18845997·Am J Clin Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 622 W 168TH ST
NEW YORK, NY 10032 - Phone
- (212) 305-7077
Quick Facts
- NPI
- 1770879223
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile